|
Absorbed dose (mGy/1 MBq 225/7Ac administered); RBE not applied
|
---|
225Ac + daughters
|
227Ac + daughters
|
---|
Alpha
|
Beta
|
Electron
|
Photon
|
Total
|
Alpha
|
Beta
|
Electron
|
Photon
|
Total
|
---|
Red marrow
|
5.40E+02
|
1.32E+00
|
1.23E+00
|
1.28E−01
|
5.43E+02
|
6.66E−03
|
1.09E−04
|
1.05E−04
|
1.62E−05
|
6.89E−03
|
Spleen
|
3.74E+02
|
8.37E−01
|
6.64E−01
|
1.62E−01
|
3.76E+02
|
6.23E−03
|
2.06E−05
|
8.56E−05
|
2.17E−05
|
6.36E−03
|
Endosteal bone surface
|
2.48E+02
|
5.75E−01
|
4.19E−01
|
5.53E−02
|
2.49E+02
|
1.81E−02
|
1.26E−04
|
9.30E−05
|
4.95E−05
|
1.84E−02
|
Liver
|
5.59E+01
|
4.13E−01
|
1.02E−01
|
7.61E−02
|
5.65E+01
|
6.82E−04
|
4.05E−06
|
9.34E−06
|
6.98E−06
|
7.03E−04
|
Lungs
|
4.48E+00
|
7.14E−02
|
9.08E−03
|
5.22E−02
|
4.61E+00
|
1.42E−04
|
4.22E−06
|
1.16E−06
|
5.52E−06
|
1.53E−04
|
Kidneys
|
1.49E+00
|
2.61E−03
|
2.71E−03
|
5.42E−02
|
1.54E+00
|
5.86E−04
|
1.38E−06
|
7.21E−06
|
7.44E−06
|
6.02E−04
|
Pancreas
|
1.34E+00
|
1.84E−02
|
2.53E−03
|
5.12E−02
|
1.41E+00
|
4.25E−05
|
9.62E−07
|
3.31E−07
|
5.56E−06
|
4.94E−05
|
Adrenals
|
1.25E+00
|
2.83E−02
|
2.77E−03
|
9.02E−02
|
1.37E+00
|
3.98E−05
|
1.64E−06
|
3.59E−07
|
9.31E−06
|
5.11E−05
|
Heart wall
|
1.11E+00
|
1.89E−02
|
2.27E−03
|
4.90E−02
|
1.18E+00
|
3.52E−05
|
9.72E−07
|
2.86E−07
|
4.83E−06
|
4.13E−05
|
Thyroid
|
9.95E−01
|
1.25E−02
|
1.84E−03
|
3.60E−02
|
1.05E+00
|
3.16E−05
|
7.87E−07
|
2.46E−07
|
4.45E−06
|
3.71E−05
|
Ovaries
|
5.46E−01
|
7.01E−03
|
1.02E−03
|
3.75E−02
|
5.91E−01
|
2.38E−04
|
7.09E−07
|
2.95E−06
|
6.00E−06
|
2.47E−04
|
Thymus
|
3.61E−01
|
1.61E−02
|
1.29E−03
|
5.32E−02
|
4.32E−01
|
1.15E−05
|
1.87E−06
|
1.59E−07
|
5.70E−06
|
1.92E−05
|
Uterus
|
3.61E−01
|
4.94E−03
|
6.80E−04
|
3.47E−02
|
4.02E−01
|
1.15E−05
|
5.15E−07
|
1.03E−07
|
6.12E−06
|
1.82E−05
|
Breast
|
3.61E−01
|
4.77E−03
|
6.74E−04
|
2.02E−02
|
3.87E−01
|
1.15E−05
|
3.11E−07
|
8.85E−08
|
2.06E−06
|
1.39E−05
|
Brain
|
2.87E−01
|
6.25E−03
|
6.61E−04
|
1.76E−02
|
3.12E−01
|
9.12E−06
|
2.78E−06
|
1.40E−07
|
4.70E−06
|
1.67E−05
|
Muscle
|
1.89E−01
|
6.02E−03
|
5.51E−04
|
2.05E−02
|
2.16E−01
|
6.00E−06
|
1.63E−06
|
9.57E−08
|
3.26E−06
|
1.10E−05
|
Salivary glands
|
0.00E+00
|
1.03E−03
|
4.50E−05
|
2.22E−02
|
2.32E−02
|
0.00E+00
|
1.99E−06
|
5.18E−08
|
4.49E−06
|
6.54E−06
|
Eye lens
|
0.00E+00
|
2.49E−05
|
1.65E−07
|
1.10E−02
|
1.10E−02
|
0.00E+00
|
6.06E−08
|
5.69E−10
|
2.95E−06
|
3.01E−06
|
- 1Assuming 0.7% 227Ac in accelerator produced 225/7Ac and that 70% of the 227Th produced by beta decay of 227Ac-labeled antibody
- remains attached to the antibody